GATINEAU, Quebec, Oct. 23, 2019 /PRNewswire/ — Digital medical technologies are driving improvements in chronic disease management, improved diagnosis, and personalized treatments as a result of access to quality data, interoperability, and care delivery. KPMG estimates that the medical device industry’s global annual sales will increase more than 5% a year to reach nearly $800 billion by 2030. Medical device companies will see continue to realize growth via product and software innovation.
“Healthcare is transforming. The way in which health conditions are treated, managed, prevented is evolving toward a patient-centric approach. I am extremely proud that Macadamian enables the innovators and disruptors in MedTech to break into new frontiers, but more so being able to help improve people’s lives.” Frederic Boulanger, CEO Macadamian Technologies
Macadamian is partnered with Healthcare Providers, Medical Research Institutes and MedTech vendors alike to develop disruptive healthcare software solutions to improve patient outcomes. Examples of Healthcare projects include:
“Having partnered with Macadamian at Medtronic for over 3 years, I did not hesitate in reaching out once again for my latest venture. I have full confidence in the depth of their expertise in healthcare to help us bring to market a disruptive Health IT solution. It is exciting to be part of Macadamian’s growth.” Paul Cox, Co-founder, Magic Medical Solutions.
December 3, 2019, at RSNA in Chicago, Macadamian will be launching a new digital health platform as a service, Macadamian HealthConnectTM. Using the HealthConnect platform as a basis for custom healthcare software development allows Macadamian to focus immediately on developing innovative functionality for clients. For Macadamian’s MedTech clients, this means reduced development costs and much faster time to market than starting application development from scratch.
Photo(s):
https://www.prlog.org/12794218
Press release distributed by PRLog
View original content:http://www.prnewswire.com/news-releases/macadamian-technologies-witnesses-300-growth-in-healthcare-revenues-becoming-an-established-software-development-partner-of-choice-in-medtech-300943638.html
SOURCE Macadamian Technologies
– Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of…
Oslo, 24 May 2025: Zelluna ASA (the "Company") refers to the resolution by the Company's…
Los Angeles, CA and Vancouver, BC, May 23, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc.…
$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon…
INDIANAPOLIS, May 23, 2025 /PRNewswire/ -- This Memorial Day Weekend, the spotlight won't only be on…
IRVING, Texas, May 23, 2025 /PRNewswire/ -- Caris Life Sciences® ("Caris"), a leading, patient-centric, next-generation AI…